1 |
Martinez B, Peplow PV. MicroRNAs as biomarkers of diabetic retinopathy and disease progression[J]. Neural Regen Res, 2019, 14(11):1858-1869.
|
2 |
Lechner J, O’Leary OE, Stitt AW. The pathology associated with diabetic retinopathy[J]. Vision Res, 2017, 139(1):7-14.
|
3 |
Peng YG, Zhang L. Wedelolactone suppresses cell proliferation and migration through AKT and AMPK signaling in melanoma[J]. J Dermatolog Treat, 2019, 30(4):389-395.
|
4 |
许静,陈杰,孙萍萍,等. 蟛蜞菊内酯抗大鼠肝缺血再灌注损伤作用的研究[J]. 时珍国医国药, 2014, 25(9):2058-2059.
|
5 |
陈杰,许静,罗子玲,等. 蟛蜞菊内酯对脂多糖诱导RAW264.7细胞IL-6、TNF-α及NF-κB的影响[J]. 时珍国医国药, 2012, 23(9):2166-2168.
|
6 |
Shahab U, Faisal M, Alatar AA, et al. Impact of wedelolactone in the anti-glycation and anti-diabetic activity in experimental diabetic animals[J]. IUBMB Life, 2018, 70(6):547-552.
|
7 |
许静,陈杰,罗子玲. 蟛蜞菊内酯对过氧化氢诱导人冠状动脉内皮细胞氧化损伤的保护作用[J]. 中国临床药理学杂志, 2019, 35(10):103-106.
|
8 |
Li X, Yu ZW, Wang Y, et al. MicroRNAs: Potential targets in diabetic retinopathy[J]. Horm Metab Res, 2020, 52(3):142-148.
|
9 |
Lu H, Yang J, Li J, et al. MiR-190 ameliorates glucotoxicity-induced dysfunction and apoptosis of pancreatic β-cells by inhibiting NOX2-mediated reactive oxygen species production[J]. PeerJ, 2022, 10:e13849.
|
10 |
Zhang Q, Xiao X, Zheng J, et al. Vildagliptin, a dipeptidyl peptidase-4 inhibitor, attenuated endothelial dysfunction through miRNAs in diabetic rats[J]. Arch Med Sci, 2019, 17(5):1378-1387.
|
11 |
张梅,李春霞,韦芳,等. 石斛酚对高糖诱导的人视网膜微血管内皮细胞的保护作用[J]. 国际眼科杂志, 2019, 19(2): 40-44.
|
12 |
Li Q, Pang L, Shi H, et al. High glucose concentration induces retinal endothelial cell apoptosis by activating p53 signaling pathway[J]. Int J Clin Exp Pathol, 2018, 11(5):2401-2407.
|
13 |
Liu L, Xu H, Zhao H, et al. STEAP4 inhibits HIF-1α/PKM2 signaling and reduces high glucose-induced apoptosis of retinal vascular endothelial cells[J]. Diabetes Metab Syndr Obes, 2020, 13(1):2573-2582.
|
14 |
Zhu MM, Wang L, Yang D, et al. Wedelolactone alleviates doxorubicin-induced inflammation and oxidative stress damage of podocytes by IκK/IκB/NF-κB pathway[J]. Biomed Pharmacother, 2019, 117(1):109088-109098.
|
15 |
Ding S, Hou X, Yuan J, et al. Wedelolactone protects human bronchial epithelial cell injury against cigarette smoke extract-induced oxidant stress and inflammation responses through Nrf2 pathway[J]. Int Immunopharmacol, 2015, 29(2):648-655.
|
16 |
陈平,魏雪梅,谈丽丽. 莫诺苷调控miR-483-5p表达对高糖诱导的人视网膜血管内皮细胞氧化应激和凋亡影响[J]. 中国临床解剖学杂志, 2023, 41(4):434-439.
|
17 |
Hwang SJ, Ahn BJ, Shin MW, et al. miR-125a-5p attenuates macrophage-mediated vascular dysfunction by targeting Ninjurin1[J]. Cell Death Differ, 2022, 29(6):1199-1210.
|
18 |
Rezazadeh-Gavgani E, Oladghaffari M, Bahramian S, et al. MicroRNA-21: A critical underestimated molecule in diabetic retinopathy[J]. Gene, 2023, 859:147212.
|
19 |
黎昌江,陈方安,洪娟,等. miR-155靶向Nrf2/HO-1通路对高糖作用下视网膜血管内皮细胞氧化应激损伤的影响[J]. 东南大学学报(医学版), 2021, 40(5):666-674.
|
20 |
Yu Y, Cao XC. miR-190-5p in human diseases[J]. Cancer Cell Int, 2019, 19(1): 257-267.
|
21 |
Sun Q, Wang S, Chen J, et al. MicroRNA-190 alleviates neuronal damage and inhibits neuroinflammation via Nlrp3 in MPTP-induced Parkinson’s disease mouse model[J]. J Cell Physiol, 2019, 234(12): 23379-23387.
|
22 |
Jiang C, Dong N, Feng J, et al. MiRNA-190 exerts neuroprotective effects against ischemic stroke through Rho/Rho-kinase pathway[J]. Pflugers Arch, 2021, 473(1): 121-130.
|
23 |
Zhai CL, Tang GM, Qian G, et al. miR-190 protects cardiomyocytes from apoptosis induced by H2O2 through targeting MAPK8 and regulating MAPK8/ERK signal pathway[J]. Int J Clin Exp Pathol, 2018, 11(4):2183-2192.
|
24 |
Liu C, Ren Y, Sui X, et al. Integrating network pharmacology, transcriptomics, and molecular simulation to reveal the mechanism of tert-butylhydroquinone for treating diabetic retinopathy[J]. Eur J Pharmacol, 2022, 931:175215.
|